[ad_1]
The University of Oxford and the pharmaceutical company AstraZeneca announced on Saturday (12) that they will resume testing of their vaccine against Covid-19. According to the statement, the safety committees assessed that there would be no reason to maintain the suspension. The information was provided by journalist Jamil Chad, from Uol.
“Clinical trials will resume at all clinical trial centers in the UK,” says the university. “Worldwide, about 18,000 people received the study vaccines as part of the trial. In large trials like this one, some participants are expected to become ill and each case must be carefully evaluated to ensure a careful safety assessment, ”she explained.
Tests around the world, including in Brazil, were suspended earlier this week due to a suspected “serious adverse reaction” in one patient. “The independent review process has been concluded and following the recommendations of both the independent safety review committee and the UK regulator, testing will be restarted in the UK,” the statement said.
Also according to the university, the patient’s medical information will not be disclosed, due to the confidentiality of the participants. “We are committed to the safety of our participants and to the highest standards of conduct in our studies and will continue to closely monitor safety,” he added.
see also
+ MasterChef: fans criticize Ana Paula Padrão’s nervousness
+ Brad Pitt launches R $ 2,150 champagne made in France
+ Shark is captured in MA with remains of missing youths in stomach
+ The telescope captures the impact of planets more than 300 light years from Earth
+ Young man is bitten on the penis by a python while in the bathroom
+ Auschwitz: Jewish women’s strategies to escape the Nazis
+ Senate approves changes to the Brazilian Traffic Code
+ What is worse for your body: sugar or salt?
+ The 10 cheapest diesel trucks in Brazil
+ Cook surrenders to Top Chef in the third episode and surprises the jury
+ Can burping a lot be a health problem?
+ Plagues, plagues, epidemics and pandemics in contemporary art
[ad_2]
